Company / SG&A Expense
uniQure N.V. SG&A Expense History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$52.7M
FY2024
5-year range
$42.6M / $74.6M
FY2020-FY2024
Trend
-29.4%
vs FY2023
Sector context
#156 of 213
Health Care
What the data says
At $53M, uniQure N.V.'s sg&a expense ranks #58 of 213 in the Health Care sector. SG&A Expense has fluctuated over the past 10 years, ranging from $23M in FY2015 to $75M in FY2023.
Based on SEC 10-K filings.
$53M in FY2024 with a 5-year CAGR of +9.4%.
Improved from $55M to $53M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -2.2%
- 5-Year CAGR
- +9.4%
- 10-Year CAGR
- -
Sector benchmark
#58 of 213 in Health CareTop 27% of 213This company $52.7M Sector average $722.3M
▼
-92.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +9.4%, indicating consistent growth.
- In FY2024, sg&a expense decreased 29.4% year-over-year.
- Ranks #156 out of 213 companies in the Health Care sector.
- Peak sg&a expense was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.58 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $52.7M | -29.4% |
| FY2023 | $74.6M | +35.5% |
| FY2022 | $55.1M | -2.2% |
| FY2021 | $56.3M | +32.2% |
| FY2020 | $42.6M | +26.9% |
| FY2019 | $33.5M | +32.6% |
| FY2018 | $25.3M | +2.7% |
| FY2017 | $24.6M | -5.2% |
| FY2016 | $26.0M | +11.2% |
| FY2015 | $23.4M | +37.0% |
As of FY2024 · SEC Form 10-K · Last checked Jul 3, 2026